Low glucose metabolism in hepatocellular carcinoma with GPC3 expression
To investigate the relationship between glucose metabolism and glypican-3 (GPC3) expression in hepatocellular carcinoma (HCC). Immunohistochemical staining of pathological samples for GPC3 and glucose transporter 1 (GLUT1), and whole-body F-FDG PET/CT for measuring tumour glucose uptake were perform...
Gespeichert in:
Veröffentlicht in: | World journal of gastroenterology : WJG 2018-01, Vol.24 (4), p.494-503 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | To investigate the relationship between glucose metabolism and glypican-3 (GPC3) expression in hepatocellular carcinoma (HCC).
Immunohistochemical staining of pathological samples for GPC3 and glucose transporter 1 (GLUT1), and whole-body
F-FDG PET/CT for measuring tumour glucose uptake were performed in 55 newly diagnosed HCC patients. The maximum standard uptake value (SUV
) and tumour-to-non-tumourous liver uptake (T/NT) ratio were used to quantify
F-FDG uptake.
F-FDG uptake assay of GPC3-expressing HepG2 and non-GPC3-expressing RH7777 cells was used to examine the effect of GPC3 in cellular glucose metabolism. The relationships between GPC3 expression and
F-FDG uptake, GLUT1 expression, tumour differentiation, and other clinical indicators were analysed using Spearman rank correlation, univariate and multiple logistic regression analyses.
Positive GPC3 expression was observed in 67.3% of HCC patients, including 75.0% of those with well or moderately differentiated HCC and 36.4% of those with poorly differentiated HCC. There was an inverse relationship between GPC3 expression and SUV
(Spearman correlation coefficient = -0.281,
= 0.038) and a positive relationship between GLUT1 expression and SUV
(Spearman correlation coefficient = 0.681,
< 0.001) in patients with HCC. Univariate analysis showed that two glucose metabolic parameters (SUV
and T/NT ratio), tumour differentiation, lymph node metastasis, and TNM stage were all significantly associated with GPC3 expression (
< 0.05), whereas GLUT1 expression, sex, age, tumour size, intrahepatic lesion number, and distant metastasis showed no statistical association (
> 0.05). Further multivariate analysis revealed that only the T/N ratio was significantly correlated with GPC3 expression in patients with HCC (
< 0.05).
assay revealed that the uptake of
F-FDG in GPC3-expressing HepG2 cells was significantly lower than that of non-GPC3-expressing RH7777 cells (
= -20.352,
< 0.001).
The present study demonstrated that GPC3 expression is inversely associated with glucose metabolism, suggesting that GPC3 may play a role in regulating glucose metabolism in HCC. |
---|---|
ISSN: | 1007-9327 2219-2840 |
DOI: | 10.3748/wjg.v24.i4.494 |